Archives

by in
Entry Author Date Location
ZymoGenetics CEO Doug Williams Exits the Stage, Mulls Next Free Agent Move 11/08/10 Seattle
ZymoGenetics Melanoma Drug Shows Survival Data, Adding More Juice to Bristol’s Pipeline 09/29/10 Seattle
Biotech Drug Discovery in Seattle: A Look Back 06/11/10 Seattle
VentiRx Nabs $25M, Gilead Deepens Seattle Roots, Sage Strikes Deal With Pfizer & More Seattle-Area Life Sciences News 01/14/10 Seattle
Alder Rises from Ashes, Seattle Genetics Gets Empowered, ZymoGenetics Nets $79M & More Seattle-Area Life Sciences News 01/07/10 Seattle
ZymoGenetics On the Prowl to Raise $85M in Stock Deal 01/06/10 Seattle
Cell Therapeutics Dangles Exec Bonuses, Oncothyreon’s Turnaround Year, VLST Layoffs, & More Seattle-Area Life Sciences News 12/24/09 Seattle
ZymoGenetics Regains Full U.S. Rights to Recothrom as Bayer Walks Away 12/21/09 Seattle
Zymo Application Yanked in EU 12/14/09 Seattle
ZymoGenetics Axes 52 Jobs, Quits Discovery of Immunology Drugs, to Conserve Cash 12/03/09 Seattle
ZymoGenetics, King Pharma Brawl Over Drugs to Control Surgical Bleeding 11/09/09 Seattle
ZymoGenetics’ Former Medical Boss Leads Rival Startup, ProFibrix, With Drug For Bleeding 10/26/09 Seattle
ZymoGenetics Plays Hardball, Targeted Genetics’ Legacy, Omeros Preps for Fall IPO, & More Seattle-Area Life Sciences News 08/27/09 Seattle
ZymoGenetics, Citing Two Patient Deaths, Builds Up Ammunition for Case Against Rival 08/20/09 Seattle
ZymoGenetics Plays Hardball, Asks FDA to Pull Competing Drug Off Market Because of Safety 08/20/09 Seattle
AVI Bolts to Seattle, OncoGenex Escapes Dendreon’s Shadow, Buddhists Helping Biotech, & More Seattle-Area Life Sciences News 08/06/09 Seattle
Zymo Gets $6M in Q2 Recothrom Sales 08/03/09 Seattle
ZymoGenetics Drug Sales Still Slumping After Full Year on Market 05/05/09 Seattle
ZymoGenetics Cuts One-Third of Workforce To Hold Onto Cash 04/29/09 Seattle
ZymoGenetics Sales Chief Exits 02/04/09 Seattle
ZymoGenetics’ New Boss Sees Parallels to Dark Days at Immunex 01/05/09 Seattle
Blood News: A Quick Rundown of Headlines From the American Society of Hematology 12/09/08 National
ZymoGenetics Drug For Surgical Bleeding Demonstrates Safety in Trial 12/08/08 Seattle
ZymoGenetics Cash Gets Lean, Recothrom Sales Still Slow 11/04/08 Seattle
ZymoGenetics’ Kidney Cancer Drug, Taken with Nexavar, Shrinks Tumors in Relapsed Patients 10/22/08 Seattle
Seattle Genetics’ Medical Point Man, Tom Reynolds, Aims to Capitalize on Hodgkin’s Drug 09/08/08 Seattle
ZymoGenetics, Bayer Drug Vying for European Regulatory Approval 09/02/08 Seattle
ZymoGenetics Sells Land for $11.5 Million 08/29/08 Seattle
ZymoGenetics Drug Getting Off to Slow Start in Marketplace 08/06/08 Seattle
ZymoGenetics Receives $100 Million Commitment From Deerfield 06/30/08 Seattle
Page 1 of 1

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  3. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  4. Do You Need an Extended Warranty? Do the Math, Says SquareTrade
  5. Automatic's App Puts Your Smartphone in Charge of Your Car

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.